NO20032148D0 - Nye anvendelser av kombinerte 5-HT1A-agonister og serotoningjenopptaksinhibitorer - Google Patents

Nye anvendelser av kombinerte 5-HT1A-agonister og serotoningjenopptaksinhibitorer

Info

Publication number
NO20032148D0
NO20032148D0 NO20032148A NO20032148A NO20032148D0 NO 20032148 D0 NO20032148 D0 NO 20032148D0 NO 20032148 A NO20032148 A NO 20032148A NO 20032148 A NO20032148 A NO 20032148A NO 20032148 D0 NO20032148 D0 NO 20032148D0
Authority
NO
Norway
Prior art keywords
combined
serotonin reuptake
reuptake inhibitors
new applications
ht1a agonists
Prior art date
Application number
NO20032148A
Other languages
English (en)
Norwegian (no)
Other versions
NO20032148L (no
Inventor
Gerd Bartoszyk
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20032148L publication Critical patent/NO20032148L/no
Publication of NO20032148D0 publication Critical patent/NO20032148D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
NO20032148A 2000-11-14 2003-05-13 Nye anvendelser av kombinerte 5-HT1A-agonister og serotoningjenopptaksinhibitorer NO20032148D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00124815 2000-11-14
PCT/EP2001/011952 WO2002040024A1 (en) 2000-11-14 2001-10-16 Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors

Publications (2)

Publication Number Publication Date
NO20032148L NO20032148L (no) 2003-05-13
NO20032148D0 true NO20032148D0 (no) 2003-05-13

Family

ID=8170369

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032148A NO20032148D0 (no) 2000-11-14 2003-05-13 Nye anvendelser av kombinerte 5-HT1A-agonister og serotoningjenopptaksinhibitorer

Country Status (21)

Country Link
US (1) US20040082594A1 (cs)
EP (1) EP1333832B1 (cs)
JP (1) JP2004513924A (cs)
KR (1) KR20030059244A (cs)
CN (1) CN1222291C (cs)
AR (1) AR031335A1 (cs)
AU (2) AU1502702A (cs)
BR (1) BR0115296A (cs)
CA (1) CA2428511C (cs)
CZ (1) CZ302484B6 (cs)
DE (1) DE60131675T2 (cs)
ES (1) ES2296820T3 (cs)
HU (1) HUP0302751A3 (cs)
MX (1) MXPA03004166A (cs)
NO (1) NO20032148D0 (cs)
PL (1) PL204331B1 (cs)
RU (1) RU2288719C2 (cs)
SK (1) SK287337B6 (cs)
UA (1) UA79583C2 (cs)
WO (1) WO2002040024A1 (cs)
ZA (1) ZA200304606B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10305739A1 (de) * 2003-02-11 2004-08-19 Merck Patent Gmbh Benzofuranderivate
WO2005061455A1 (en) 2003-12-23 2005-07-07 H. Lundbeck A/S 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri
EP1732610A2 (en) * 2004-03-26 2006-12-20 Baylor University Targeted serotonin reuptake inhibitors
AR052308A1 (es) 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
WO2006034788A1 (en) * 2004-09-28 2006-04-06 Merck Patent Gmbh Combinations of n-(indolecarbonyl-)piperazine derivatives and serotonin reuptake inhibitors
US7629473B2 (en) 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
AR054393A1 (es) 2005-06-17 2007-06-20 Lundbeck & Co As H Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos.
KR20090078777A (ko) * 2006-08-11 2009-07-20 디에스엠 아이피 어셋츠 비.브이. 중추 신경계 질환의 치료를 위한 리구스틸라이드 유도체

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4333254A1 (de) * 1993-09-30 1995-04-06 Merck Patent Gmbh Piperidine und Piperazine
DE19512639A1 (de) * 1995-04-05 1996-10-10 Merck Patent Gmbh Benzonitrile und -fluoride
DE19637237A1 (de) * 1996-09-13 1998-03-19 Merck Patent Gmbh Piperazin-Derivate
DE19730989A1 (de) * 1997-07-18 1999-01-21 Merck Patent Gmbh Piperazin-Derivate
WO2000005225A1 (en) * 1998-07-20 2000-02-03 Merck Patent Gmbh Biphenyl derivatives

Also Published As

Publication number Publication date
PL360310A1 (en) 2004-09-06
JP2004513924A (ja) 2004-05-13
PL204331B1 (pl) 2010-01-29
RU2288719C2 (ru) 2006-12-10
DE60131675D1 (de) 2008-01-10
HUP0302751A2 (hu) 2003-11-28
CN1222291C (zh) 2005-10-12
WO2002040024A1 (en) 2002-05-23
DE60131675T2 (de) 2008-11-20
HUP0302751A3 (en) 2007-06-28
AU2002215027B2 (en) 2006-10-05
AU1502702A (en) 2002-05-27
ES2296820T3 (es) 2008-05-01
CA2428511A1 (en) 2002-05-23
MXPA03004166A (es) 2003-09-22
CZ20031433A3 (cs) 2003-09-17
SK287337B6 (sk) 2010-07-07
KR20030059244A (ko) 2003-07-07
CZ302484B6 (cs) 2011-06-08
HK1060697A1 (en) 2004-08-20
CN1474691A (zh) 2004-02-11
BR0115296A (pt) 2003-09-02
EP1333832A1 (en) 2003-08-13
AR031335A1 (es) 2003-09-17
UA79583C2 (en) 2007-07-10
SK6382003A3 (en) 2003-11-04
CA2428511C (en) 2009-12-29
ZA200304606B (en) 2004-09-13
EP1333832B1 (en) 2007-11-28
NO20032148L (no) 2003-05-13
US20040082594A1 (en) 2004-04-29

Similar Documents

Publication Publication Date Title
NO20032465L (no) Nye mandelsyre-derivater og anvendelse derav som trombininhibitorer
NO20034308L (no) Nye tyrokinase-inhibitorer
CY2014022I1 (el) Παραγωγα φαινυλ-πιπεραζινης ως αναστολεις επαναπροσληψης σεροτονινης
NO20031744L (no) Nye ikke-imadazolforbindelser og farmasöytisk preparat omfattende slike
NO20033261D0 (no) Nye blandinger av mikrobielle enzymer
IS2529B (is) Nýjar spírótrísýklískar afleiður og notkun þeirra sem fosfódíesterasa-7-hindrar
NO20044194L (no) Nye inhibitorer av histon-deacetylase
ATE398107T1 (de) N-pyrrolidin-3-yl-amide-derivate als inhibitoren der serotonin- und noradrenalin-wiederaufnahme
NO20033491D0 (no) Heterocykliske inhibitorer av ERK2 og anvendelser derav
DK1499311T3 (da) Substituerede benzaboler og anvendelse deraf som RAF-kinaseinhibitorer
NO20041272L (no) Tetracycline derivatives and methods of use thereof
IS5406A (is) Samsetning 5-HT endurupptökuhemils og h5-HT1B mótlyfs eða gerandefnis með hlutaverkun
NO20032148D0 (no) Nye anvendelser av kombinerte 5-HT1A-agonister og serotoningjenopptaksinhibitorer
NO20023662D0 (no) Nye heterocykliske derivater, fremgangsmåte ved fremstilling og farmasöytiske sammensetninger inneholdende det samme
ATE499096T1 (de) Kombination von serotonin-wiederaufnahme-hemmern und agomelatin
IS6960A (is) Fenýl heterósýklýl eter afleiður sem serótónín endurupptökuhindrar
NO20023956D0 (no) Priperidin- og piperazinsubstituerte N-hydroksyformamider som inhibitorer av metalloproteinaser
NO20032248L (no) Ny anvendelse av kombinerte 5-HT1A-agonister og selektive inhibitorer for serotoningjenopptaksinhibitorer
ATE449633T1 (de) Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern
NO20035331D0 (no) Nye heterocyklisk forbindelse og medisinsk anvendelse derav
NO20010685D0 (no) Nye farmasöytiske anvendelser av NOS inhibitorer
NO20025509D0 (no) Ny polymorf av torasemid
FI20031191L (fi) Monoamiinin takaisinoton estäjä
DK1146041T3 (da) Derivater af heterocycloalkylbenzocyclobutan og heteroarylbenzocyclobutan og deres anvendelse som inhibitorer for genoptagelse af serotonin og noradrenalin
NO20035647L (no) Ny anvendelse av cyclolignaner og nye cycloliganer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application